These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2887053)

  • 1. New therapy for impotence.
    Orvis BR; Lue TF
    Urol Clin North Am; 1987 Aug; 14(3):569-81. PubMed ID: 2887053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnosis and treatment of erectile dysfunction].
    Loran OB; Sheplev PA; Nesterov SN
    Urol Nefrol (Mosk); 1998; (3):39-46. PubMed ID: 9644990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes-related impotence and its treatment in the middle-aged and elderly: Part II.
    Whitehead ED
    Geriatrics; 1987 Aug; 42(8):77-80, 85. PubMed ID: 3596258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic treatment of impotence.
    Malloy TR; Malkowicz B
    Urol Clin North Am; 1987 May; 14(2):297-305. PubMed ID: 2883750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Priapism as a complication of the treatment of impotence by local injections of papaverine].
    Kaczmarek A
    Wiad Lek; 1990 Sep 1-15; 43(17-18):908-10. PubMed ID: 2278150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic and therapeutic applications of intracavernous injection of vasoactive drugs in impotence. Defense for the use of facilitating drugs. Part I--Pharmacology, classification and complications of active drugs].
    Buvat J; Buvat-Herbaut M; Lemaire A; Marcolin G
    J Urol (Paris); 1989; 95(1):33-9. PubMed ID: 2567318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current treatment and future perspectives for erectile dysfunction.
    Hatzichristou DG
    Int J Impot Res; 1998 May; 10 Suppl 1():S3-13. PubMed ID: 9669215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Response to intracavernous administration of 3 different drugs in the same group of patients with erectile dysfunction].
    Ribé N; Rajmil O; Bassas L; Jurado C; Pomerol JM
    Arch Esp Urol; 2001 May; 54(4):355-9. PubMed ID: 11455770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current role of intracavernous therapy in the treatment of erectile dysfunction].
    Asuar Aydillo S
    Arch Esp Urol; 2002 Jun; 55(5):475-82. PubMed ID: 12174413
    [No Abstract]   [Full Text] [Related]  

  • 10. Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction.
    Meinhardt W; de la Fuente RB; Lycklama à Nijeholt AA; Vermeij P; Zwartendijk J
    Int J Impot Res; 1996 Mar; 8(1):5-7. PubMed ID: 8735187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Topical therapy in erectile dysfunction].
    Floth A
    Wien Med Wochenschr; 2000; 150(1-2):14-7. PubMed ID: 10746290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injection therapy for impotence.
    Kursh ED; Bodner DR; Resnick MI; Althof SE; Turner L; Risen C; Levine SB
    Urol Clin North Am; 1988 Nov; 15(4):625-9. PubMed ID: 3055615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What nonresponse to intracavernous injection really indicates: a determination by quantitative analysis.
    Elhanbly S; Schoor R; Elmogy M; Ross L; Hegazy A; Niederberger C
    J Urol; 2002 Jan; 167(1):192-6. PubMed ID: 11743303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis and therapy of erectile impotence with special reference to papaverine].
    Schnyder von Wartensee M; Studer UE
    Schweiz Med Wochenschr; 1986 Jul; 116(30):994-9. PubMed ID: 3529377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and evaluation of nitrosylated alpha-adrenergic receptor antagonists as potential agents for the treatment of impotence.
    de Tejada IS; Garvey DS; Schroeder JD; Shelekhin T; Letts LG; Fernández A; Cuevas B; Gabancho S; Martínez V; Angulo J; Trocha M; Marek P; Cuevas P; Tam SW
    J Pharmacol Exp Ther; 1999 Jul; 290(1):121-8. PubMed ID: 10381767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of impotence after treatment of carcinoma of the prostate.
    Telang DJ; Farah RN
    Henry Ford Hosp Med J; 1992; 40(1-2):111-3. PubMed ID: 1428960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Surgical therapy of vascular impotence].
    Schnyder von Wartensee M; Studer UE
    Schweiz Med Wochenschr; 1988 Sep; 118(35):1237-41. PubMed ID: 3187467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intracavernous auto-injection therapy with papaverine phentolamine via an auto-injection pen for patients with an erectile dysfunction: similar results achieved in family practice and urology].
    de Boer BJ; Lycklama a Nijeholt AA; Kleinjans HA
    Ned Tijdschr Geneeskd; 2001 Apr; 145(16):783-7. PubMed ID: 11346917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of clinical usefulness of direct drug injections for increasing local circulation, into cavernous bodies of the penis for treatment of erection impotence in patients with diabetes mellitus].
    Dembe K; Jasik M; Piechna K
    Pol Tyg Lek; 1994 Jan 3-17; 49(1-3):19-20. PubMed ID: 8008670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intracavernous injections: role in the diagnosis and therapy of problems in erection].
    Jardin A; Benoit G; Giuliano F
    Journ Annu Diabetol Hotel Dieu; 1993; ():359-74. PubMed ID: 8101244
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.